FTSE Developed Europe UCITS ETF
FTSE Developed Europe UCITS ETF - (EUR) Distributing (VEUR)
Related Documents
About this fund
Fund objectives
- The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE Developed Europe Index (the “Index”).
- The Index is comprised of large and mid-sized company stocks in developed markets in Europe.
- The Fund attempts to: 1. Track the performance of the Index by investing in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in extraordinary market, political or similar conditions.
Fund facts
Share class inception
21 May 2013
Listing date
22 May 2013
Investment structure
Irish UCITS
Share Class Assets'
Total Assets
Risk indicator
Strategy
Index
Asset Class
Equity
Investment method
Physical
Index ticker
TAWNT06E
Benchmark
FTSE Developed Europe Index
Dividend schedule
Quarterly
Domicile
Ireland
Legal entity
Vanguard Funds PLC
Register countries
Ireland, Liechtenstein, France, Norway, Netherlands, United Kingdom, Croatia, Germany, Denmark, Portugal, Czech Republic, Romania, Chile, Austria, Estonia, Mexico, Iceland, Switzerland, Belgium, Hungary, Spain, Lithuania, Cyprus, Slovenia, Sweden, Bulgaria, Luxembourg, Malta, Latvia, Slovakia, Finland, Greece and Italy
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
As at 31 Oct 2026
Beta
R²
Annualized Tracking Error
1 year
3 years
5 years
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 509 | 491 | 30 Sep 2026 |
| Median market capital | 79.1 B | 79.1 B | 31 Oct 2026 |
| 16.7 x | 16.7 x | 31 Oct 2026 | |
| 2.4 x | 2.4 x | 31 Oct 2026 | |
| 14.2% | 14.2% | 31 Oct 2026 | |
| 10.7% | 10.7% | 31 Oct 2026 | |
| Portfolio turnover rate | -14.3% | — | 30 Sep 2026 |
Market allocation
As at 30 Sep 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United Kingdom | Europe | 22.84% | 22.84% | 0.00% |
| France | Europe | 14.09% | 14.09% | 0.00% |
| Switzerland | Europe | 14.05% | 14.05% | 0.00% |
| Germany | Europe | 13.29% | 13.29% | 0.00% |
| Netherlands | Europe | 8.75% | 8.75% | 0.00% |
| Spain | Europe | 6.28% | 6.28% | 0.00% |
| Italy | Europe | 5.61% | 5.61% | 0.00% |
| Sweden | Europe | 5.06% | 5.06% | 0.00% |
| Denmark | Europe | 2.38% | 2.38% | 0.00% |
| Finland | Europe | 1.80% | 1.80% | 0.00% |
| Belgium | Europe | 1.76% | 1.76% | 0.00% |
| Norway | Europe | 1.04% | 1.04% | 0.00% |
| Poland | Europe | 0.88% | 0.88% | 0.00% |
| Austria | Europe | 0.69% | 0.69% | 0.00% |
| Ireland | Europe | 0.62% | 0.62% | 0.00% |
Holdings details
As at 31 Oct 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 4.22074% | Technology | NL | €342,793,315.20 | 242,634 |
| Roche Holding AG | 2.39119% | Health Care | CH | €194,203,684.31 | 442,312 |
| Shell PLC | 2.18939% | Energy | GB | €177,814,417.40 | 3,670,723 |
| Novartis AG | 2.10282% | Health Care | CH | €170,783,007.23 | 1,172,899 |
| HSBC Holdings PLC | 2.03565% | Financials | GB | €165,328,479.27 | 10,788,135 |
| AstraZeneca PLC | 1.94498% | Health Care | GB | €157,964,374.58 | 942,895 |
| Nestle SA | 1.83663% | Consumer Staples | CH | €149,164,235.89 | 1,618,037 |
| SAP SE | 1.59860% | Technology | DE | €129,832,137.50 | 614,590 |
| Siemens AG | 1.49268% | Industrials | DE | €121,229,643.15 | 456,351 |
| TotalEnergies SE | 1.32589% | Energy | FR | €107,683,916.99 | 1,260,493 |
Prices and distribution
Prices
NAV Price (EUR)
€51.33
EURChange
+€0.010.03% At closure 13 Nov 2026
Market value (EUR)
€51.44
Change
-€0.01-0.01% At closure 13 Nov 2026
NAV 52-week high
€51.33
At closure 15 Nov 2026
Market value 52-week high
€51.45
At closure 15 Nov 2026
NAV 52-week low
€43.39
At closure 15 Nov 2026
Market value 52-week low
€43.43
At closure 15 Nov 2026
NAV 52-week difference
€7.94
Change
+15.46% At closure 15 Nov 2026
Market value 52-week difference
€8.02
Change
+15.59% At closure 15 Nov 2026
Outstanding shares
96,980,427
At closure 31 Oct 2026
Historical Prices
-
Inception date
21 May 2013
Listing date
04 Jun 2013
| Date | NAV (EUR) | Market price (EUR) |
|---|---|---|
| 13 Nov 2026 | €51.3320 | €51.4420 |
| 12 Nov 2026 | €51.3178 | €51.4490 |
| 11 Nov 2026 | €51.2238 | €51.3380 |
| 10 Nov 2026 | €50.8536 | €50.9570 |
| 09 Nov 2026 | €50.7149 | €50.8670 |
| 06 Nov 2026 | €50.0830 | €50.2130 |
| 05 Nov 2026 | €50.5880 | €50.7920 |
| 04 Nov 2026 | €50.7694 | €50.9060 |
| 03 Nov 2026 | €49.8450 | €49.9200 |
| 02 Nov 2026 | €50.1431 | €50.2640 |
Distribution history
Distribution frequency
Quarterly
Historical performance 31 Oct 2026
2.65%
| Type | Distribution amount (per unit) | Ex-dividend date | Registration date | Payable date |
|---|---|---|---|---|
| Income | €0.1944 | 17 Sep 2026 | 18 Sep 2026 | 30 Sep 2026 |
| Income | €0.7814 | 18 Jun 2026 | 19 Jun 2026 | 01 Jul 2026 |
| Income | €0.1815 | 19 Mar 2026 | 20 Mar 2026 | 01 Apr 2026 |
| Income | €0.1676 | 18 Dec 2025 | 19 Dec 2025 | 31 Dec 2025 |
| Income | €0.1609 | 18 Sep 2025 | 19 Sep 2025 | 01 Oct 2025 |
| Income | €0.7630 | 19 Jun 2025 | 20 Jun 2025 | 02 Jul 2025 |
| Income | €0.1872 | 20 Mar 2025 | 21 Mar 2025 | 02 Apr 2025 |
| Income | €0.1542 | 12 Dec 2024 | 13 Dec 2024 | 27 Dec 2024 |
| Income | €0.1605 | 12 Sep 2024 | 13 Sep 2024 | 25 Sep 2024 |
| Income | €0.7398 | 13 Jun 2024 | 14 Jun 2024 | 26 Jun 2024 |
Purchase information
Currencies and stock exchanges
Listed currencies: GBP, EUR, CHF, USD, MXN
Base currency:EUR
Exchanges: London Stock Exchange, NYSE Euronext - Amsterdam, SIX Swiss Exchange, Deutsche Boerse, Bolsa Mexicana De Valores, Borsa Italiana S.p.A.